Life Sciences and Health Care companies are facing enormous challenges and unpredictable changes in the coming years. Regulatory pressures are increasing. New medical advances occur daily. Patent rule changes require careful management of all IP portfolios. Increased potential liability relating to products and services requires continual vigilance. Government and regulatory scrutiny is at an all-time high. Commercial and government payers alike demand more effective cost controls. To meet these and other challenges, law firms who understand this sector can effectively represent the issues and interests at hand.
BASEAK lawyers focus on the issues that are the core of the life sciences and health care business. We provide advice to life sciences and healthcare companies in a wide array of services across the spectrum of the healthcare sector.
We advise on:
- Intellectual property rights
- Best procurement practices
- Government regulatory policies and enforcement
- Patient confidentiality
- Corporate transactions
- Mergers and acquisitions
We collaborate with consultants in health care delivery, pharma-economic experts, management advisers, and leaders in scientific opinion and research institutes.
We work closely with health care establishments and services providers and research centers, as well as international pharmaceutical companies, health care and life sciences players.
Our experience encompasses the full range of issues faced by Health Care and Life Sciences businesses.
May 26, 2016
August 11, 2015
The demand for high quality public services, particularly with respect to health care, is growing rapidly in Turkey. This demand will only accelerate given the growing expectations of Turkey’s increasingly modern and sophisticated population. To satisfy this booming demand, the private sector—with its often superior access to resources, including financial, and its use of international best practices—is increasingly being tapped by the Turkish government to assist it in the provision of these public services. Read more
In recent years, Turkey made major developments in the pharmaceutical industry. Considering the Association of Research-Based Pharmaceutical Companies’ (AIFD) “Ranking of Countries in Pharmaceutical Market” research in 2013, Turkey was in the 18th place and expected to be in the 16th by the end of 2018. Read more
News and Events
Recent Press Releases
May 20, 2019
January 5, 2017
Balcıoğlu Selçuk Akman Keki Attorney Partnership advised Taxim Capital on Besifarma İlaç A.Ş.’s investment in Alke Sağlık Ürünleri Sanayi ve Ticaret A.Ş. Read more
October 2, 2015
Balcıoğlu Selçuk Akman Keki Attorney Partnership team, led by Partner Doğan Eymirlioğlu, succesfully advised Pera Capital on its acquisition of 45% of the shares of Asset Medikal. Read more
BASEAK team, led by Partner Doğan Eymirlioğlu, successfully assisted the shareholders of Muka Metal A.Ş., a privately held business headquartered in Kayseri, on the sale of its shares to Stryker Corporation, one of the world's leading medical technology companies. This acquisition is the first investment for Stryker in Turkey. Read more